"We're trying to move away a little bit from the notion that seven out of eight or six out of eight is better than five out ...

Less emphasis on full HLA matching means clinicians can find an appropriate donor for any patient, says Antonio Jimenez ...

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

Although improved prophylaxis with post-transplant cyclophosphamide has reduced the chances of graft-vs-host disease developing, the problem has not disappeared entirely, says Antonio Jimenez Jimenez, ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

After a one-year follow-up, 10 of 12 patients given the islet cell therapy zimislecel no longer required insulin. Vertex ...

A panelist discusses how the most effective therapy for squamous cell anal carcinoma is prevention through human ...

A panelist discusses how the POD1UM-303 randomized phase 3 trial demonstrated that adding retifanlimab (a PD-1 inhibitor) to ...

Results come after positive results from a trial among people with idiopathic pulmomary disease.

In a conversation with Managed Healthcare Executive, Michael Abrams, M.A., managing partner at Numerof & Associates, painted ...

An investigational oral targeted therapy, zipalertinib (CLN-081), demonstrated meaningful tumor responses and a manageable ...